Craig A. Bunnell
Assistant Professor
Breast OncologyÂ
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Bunnell received his MD from Harvard Medical School and his MPH from Harvard School of Public Health in 1990. He received his MBA from the Massachusetts Institute of Technology in 2008. He completed his residency in internal medicine and a fellowship in hematology and oncology at Brigham and Women's Hospital, where he also served as chief medical resident. He joined Dana-Farber in 1996, and is a member of the Breast Oncology Center in the Susan F. Smith Center for Women's Cancers. Dr. Bunnell was named Dana-Farber's Chief Medical Officer in 2012.
Research Interest
Breast cancer, Quality of life, Symptom control
Publications
-
Bunnell C, Vahdat L, Schwartzberg L, Gralow J, Klimovsky J (2008) Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer. Clin Breast Cance 3 :234-241.
-
Bunnell CA, Shulman LN (2010) Will we be able to care for cancer patients in the future? Oncology (Williston Park). 14 :1343-1348.
-
Bunnell CA1, Gross AH, Weingart SN, Kalfin MJ, Partridge A et al (2013) High performance teamwork training and systems redesign in outpatient oncology. BMJ Qual Saf. 5 :405-413.
